意大利人群队列中已知ALS基因的突变分析
该研究对意大利皮埃蒙特和瓦莱达奥斯塔地区基于人群的队列中959例ALS患者和677名匹配健康对照进行全基因组测序,分析40个已知ALS基因。结果显示11.9%的患者携带潜在致病变异,SOD1罕见变异是仅次于C9orf72扩增的第二常见病因,TARDBP信号较弱,其他已知基因贡献有限。
要点
- 在959例ALS患者中,11.9%检出潜在致病性变异。
- SOD1罕见变异是仅次于C9orf72扩增的第二常见遗传病因。
- 其他已知ALS基因的罕见变异对疾病风险贡献有限。
核心结论
- 在意大利基于人群的ALS队列中,11.9%的患者携带潜在致病性变异,SOD1罕见变异是仅次于C9orf72扩增的第二常见病因。
研究设计与样本
- 对来自意大利皮埃蒙特和瓦莱达奥斯塔ALS登记处(PARALS)的959例ALS患者和677名匹配健康对照进行全基因组测序,并分析40个已知ALS基因。
主要发现
- 基因-wide关联检验显示SOD1与ALS强关联,其罕见变异是仅次于C9orf72扩增的第二常见病因。
- TARDBP关联信号较弱,其效应由少数已知致病性变异驱动。
- 其他已知ALS基因的罕见变异未达到基因-wide检验的统计学显著性,提示其在本队列中疾病风险贡献有限。
临床怎么用
- 全基因组测序可作为ALS诊断工具,有助于识别潜在致病性变异。
- 在意大利人群中,SOD1罕见变异是重要的遗传检测目标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the burden of rare genetic variants and to estimate the contribution of known amyotrophic lateral sclerosis (ALS) genes in an Italian population-based cohort, we performed whole genome sequencing in 959 patients with ALS and 677 matched healthy controls. METHODS: We performed genome sequencing in a population-based cohort (Piemonte and Valle d'Aosta Registry for ALS [PARALS]). A panel of 40 ALS genes was analyzed to identify potential disease-causing genetic variants and to evaluate the gene-wide burden of rare variants among our population. RESULTS: A total of 959 patients with ALS were compared with 677 healthy controls from the same geographical area. Gene-wide association tests demonstrated a strong association with SOD1, whose rare variants are the second most common cause of disease after C9orf72 expansion. A lower signal was observed for TARDBP, proving that its effect on our cohort is driven by a few known causal variants. We detected rare variants in other known ALS genes that did not surpass statistical significance in gene-wise tests, thus highlighting that their contribution to disease risk in our cohort is limited. CONCLUSIONS: We identified potential disease-causing variants in 11.9% of our patients. We identified the genes most frequently involved in our cohort and confirmed the contribution of rare variants in disease risk. Our results provide further insight into the pathologic mechanism of the disease and demonstrate the importance of genome-wide sequencing as a diagnostic tool.
引用
- Grassano M, Calvo A, Moglia C, et al. Mutational Analysis of Known ALS Genes in an Italian Population-Based Cohort. Neurology. 2020. PMID: 33208543. doi:10.1212/WNL.0000000000011209
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。